Casopitant (GW679769) is a potent, selective, brain-penetrant and orally active neurokinin 1 ( NK 1 ) receptor antagonist. Casopitant antagonizes the emetic effects of Substance P ( HY-P0201 ). Casopitant is also a substrate and weak to moderate inhibitor of CYP3A4 . Casopitant is indicated for chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV).
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Neurokinin Receptor | Products > Signaling Pathways > Cytochrome P450
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.